SpectraLIT, a Compact Development Kit for Spectral Analysis Applications Introduced by Newsight Imaging

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

June 12, 2020

Newsight Imaging, the CMOS image sensor chip maker for 3D machine vision and spectral analysis applications announced the release of its SpectraLIT, a compact development kit suitable for testing Newsight technology and developing proof-of-concept devices for the healthcare and food & beverage industries or other liquids analysis.

SpectraLIT™ is a development kit based on Newsight’s spectrometer-on- chip. It allows for spectral profiling of substances in wavelengths between 400 to 700 nm in a matter of seconds. The next generation of SpectraLIT™️ will be able to support wavelengths between 400 to 1100 nm. The kit will allow diagnostic and analytical companies a fast market introduction of a portable, and low-cost diagnosis device. SpectraLIT is controlled by a Windows-based demo SW that displays, analyzes and stores the spectral profiles of the tested substance.

SpectraLIT uses standard cuvettes, which are easily inserted through a slide covered by a top lid, allowing full isolation of the tested substance from any external ambient light.

Using a special developed algorithm, SpectraLIT can compare the tested substance’s spectral profiles to profiles stored in a local database, allowing detection and identification of matching substances previously analyzed by SpectraLIT.

Newsight is now offering its potential partners to develop its POC based on SpectraLIT™. Upon achieving successful implementation, Newsight is offering its partner to license the technology, acquire the spectral chips or use a ready-made module to build their own game changing device.

On June 16th, 16:00 pm CEST, Newsight will conduct a free live webinar demonstrating SpectraLIT™ for potential future partners who will be interested in building an immediate, portable, and affordable detection device based on spectral profiling technology. To register here.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.